Paul S. Djuricich, PharmD AAHIV

Clinical Pharmacy Specialist
University of Chicago Medicine

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-546) Eligibility and Factors Associated with Long-Acting Injectable Cabotegravir – Rilpivirine Initiation in a South Side Chicago HIV Clinic
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT